US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 3.710
  • -0.040-1.07%
Close Aug 16 16:00 ET
  • 3.720
  • +0.010+0.27%
Post 20:02 ET
700.38MMarket Cap-8244P/E (TTM)

Arbutus Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arbutus Biopharma Q2 2024 Earnings Date

Currency：USDAug 1, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.76M
1.73M
-32.45K
Miss Est.
-62.43%
-62.89%
-1.85%
EPS
-0.10
-0.11
-0.01
Miss Est.
+4.78%
-10.00%
-14.94%
Analyst Rating
Strong Buy

Aug 1, 2024

Arbutus Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.699M--
--2024/Q3-- / 2.576M--
Aug 1, 20242024/Q22.390M / 2.415M--
May 2, 20242024/Q12.108M / 3.682M--
Feb 29, 20242023/Q42.912M / 6.512M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.699M--
--2024/Q3-- / 2.576M--
Aug 1, 20242024/Q22.390M / 2.415M--
May 2, 20242024/Q12.108M / 3.682M--
Feb 29, 20242023/Q42.912M / 6.512M--

Unlock Free Earnings Estimates

Arbutus Biopharma Earnings Reports

  • Arbutus Biopharma | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:53 ET

  • Arbutus Biopharma | 10-Q: Q1 2024 Earnings Report

    May 2 16:40 ET

  • Arbutus Biopharma | 10-K: FY2023 Annual Report

    Mar 5 16:54 ET

  • Arbutus Biopharma | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 16:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 1, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg